Evidence map›Paper›PMID 31805930›Full record

ArticleBMC health services research2019

Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register study.

Linda Aagaard Rasmussen, Henry Jensen, Line Flytkjær Virgilsen, Alina Zalounina Falborg, Henrik Møller, Peter Vedsted

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Detecting cancer recurrence in general practice: a Danish national cohort study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  2. Clinical assessment of recurrent cancer: a Danish cohort study in general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  3. Article
  4. Diagnosis and management of cancer recurrence: a clinical update for GPs.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Linda Aagaard RasmussenResearch Unit for General Practice, Aarhus, Denmark. linda.rasmussen@ph.au.dk.ORCID http://orcid.org/0000-0002-9753-2008
Henry JensenResearch Unit for General Practice, Aarhus, Denmark.
Line Flytkjær VirgilsenResearch Unit for General Practice, Aarhus, Denmark.
Alina Zalounina FalborgResearch Unit for General Practice, Aarhus, Denmark.
Henrik MøllerResearch Unit for General Practice, Aarhus, Denmark.
Peter VedstedResearch Unit for General Practice, Aarhus, Denmark.
Aarhus University · DK

Funding

Aarhus University n.a.Danish Cancer Society n.a.Danish General Practice Fund n.a.Primary Health Care Research Fundation of the Central Denmark Region n.a.
6 · The paper itself

Abstract

backgroundThe organisation of cancer follow-up is under scrutiny in many countries, and general practice is suggested to become more involved. A central focus is timely detection of recurring previous cancer and new second primary cancer. More knowledge on the patient pathway before cancer recurrence and second primary cancer is warranted to ensure the best possible organisation of follow-up. We aimed to describe the healthcare utilisation in the year preceding a diagnosis of cancer recurrence or second primary cancer.

methodsThis nationwide register study comprises patients diagnosed with bladder, breast, colorectal, endometrial, lung, malignant melanoma and ovarian cancer in Denmark in 2008-2016. The frequency of healthcare contacts during the 12 months preceding a cancer recurrence or second primary cancer was estimated and compared to the frequency of cancer survivors in cancer remission. The main analyses were stratified on sex and healthcare setting. Furthermore, two sub-analyses were stratified on 1) sex, healthcare setting and age group and on 2) sex, healthcare setting and comorbidity status.

resultsThe study population consisted of 7832 patients with recurrence and 2703 patients with second primary cancer. On average, the patients were in contact with general practice one time per month in the 12th month preceding a new cancer diagnosis (recurrence or second primary cancer). Increasing contact rates were seen from 7 months before diagnosis in general practice and from 12 months before diagnosis in hospitals. This pattern was more pronounced in patients with cancer recurrence, younger patients and patients with no comorbidity. For instance, the contact rate ratios for hospital contacts in non-comorbid women with recurrence demonstrated 30% more contacts in the 12th month before recurrence and 127% more contacts in the 2nd month before recurrence.

conclusionsThe results show that cancer survivors are already seen in general practice on a regular basis. The increasing contact rates before a diagnosis of cancer recurrence or second primary cancer indicate that a window of opportunity exists for more timely diagnosis; this is seen in both general practice and in hospitals. Thus, cancer survivors may benefit from improvements in the organisation of cancer follow-up.

Indexed as

AdolescentAdultAgedAged, 80 and overDenmarkFemaleGeneral PracticeHospitalsHumansMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasms, Second PrimaryPatient Acceptance of Health CareRegistriesYoung AdultCancer survivorsCare transitionDelivery of healthcarePrimary health careRecurrenceSecond primary neoplasms

Identifiers

PMID31805930
PMCPMC6896499
OpenAlexW2992915058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.